|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||82.30 - 82.93|
|52 Week Range||66.72 - 92.97|
|PE Ratio (TTM)||11.46|
|Dividend & Yield||3.30 (3.49%)|
|1y Target Est||N/A|
Spectrum Pharmaceuticals, Inc. (SPPI) initiated the registrational phase III study of qapzola in patients with non-muscle invasive bladder cancer (NMIBC) as per the FDA's requirement.
Sanofi (SNY), one of the world's largest pharmaceutical companies, reported operational growth of 5.5% to reach revenue of 8.7 billion euros in 2Q17.
After a lull, the Zika virus was back in headlines early last week, as the Florida Department of Health confirmed the first sexually transmitted Zika case of 2017 in Pinellas County. The release from the ...